Treatment of chronic allograft rejection with anti-angiogenic agents
US6218361A · kind A · utility
0Cited by
2References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 25, 1998 |
| Grant date | Apr 17, 2001 |
| Priority date | — |
| Expiry date | Nov 25, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates a method of inhibiting chronic allograft rejection in a subject with an organ transplant. The method comprises administering an effective amount of one or more anti-angiogenic agents to a subject alone or in combination with one or more immunosuppressive agents. The invention provides new and improved methods of inhibiting allograft rejection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.